CAMK2N1 is generally considered as a tumor suppressor gene, which is reduced and associated with poor clinical outcomes in hepatocellular carcinoma, medullary thyroid cancer, cervical cancer, or ovarian cancer [24–27]. This evidence concerns the gene CAMK2N1 and hepatocellular carcinoma.